Joshua Silverman Petros Pharmaceuticals, Inc. (PTPI) insider trading activity

Joshua Silverman is Director of Petros Pharmaceuticals, Inc.. Currently has a direct ownership of 1.01 Million shares of PTPI, which is worth approximately $50,561. The most recent transaction as insider was on Feb 19, 2025, when has been sold 1,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.01M

8899.17% 3M change

8899.17% 12M change

Total Value Held $50,561

Joshua Silverman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 19 2025	BUY Grant, award, or other acquisition	-	1,000,000 Added 49.72%	1,011,237 Common Stock
Apr 26 2023	BUY Exercise of conversion of derivative security	-	6,722 Added 37.43%	11,237 Common Stock
Jan 20 2023	BUY Exercise of conversion of derivative security	-	2,515 Added 35.78%	4,515 Common Stock
Dec 01 2020	BUY Grant, award, or other acquisition	-	20,000 Added 50.0%	20,000 Common Stock, par valu...

Also insider at

AYRO

AYRO, Inc. Consumer Cyclical

Executive Chairman

MYMD

MyMD Pharmaceuticals, Inc. Healthcare

Director

SNPX

Synaptogenix, Inc. Healthcare

Director

FEMY

FEMASYS INC Healthcare

PMCB

PharmaCyte Biotech, Inc. Healthcare

Interim CEO, Interim President